[19]. Apparently, the ERK/MEK inhibitors aren't ATP competitive but instead act to prevent the MAPKKK, Raf1 from activating MEK and thus their noticed relative lack of Unwanted effects probably displays that they don't non-precisely inhibit other kinases in vivo The authors verify that the information supporting the findings of this https://georgez219fpw9.robhasawiki.com/user